The March 2026 FOCM | GLSA Virtual Networking Event Recap Event Date: March 18, 2026 The March 2026 GLSA / FOCM Virtual Networking Event brought together a dynamic group of life sciences leaders, innovators, and problem-solvers for an engaging session focused on connection, collaboration, and forward-thinking strategy. From industry challenges to the evolving role of… Read more »
News & Events
The April 2026 | Accelerated Partnering Session Recap
GLSA Accelerated Partnering: AI, Regulatory Readiness, and the Future of Smarter Clinical Development Event Date: April 2026 The April 2026 GLSA Accelerated Partnering Session brought together industry leaders for a focused discussion on the growing role of artificial intelligence in life sciences. Throughout the session, participants explored how AI-driven solutions are being applied across clinical… Read more »
GLSA’s Innovative Solutions for Clinical Research Success
How GLSA’s Clinical Research Technology Solutions Enhance Preclinical and Clinical Research In the dynamic world of life sciences, the journey from discovery to market approval is filled with challenges. Organizations face numerous scientific, regulatory, and logistical hurdles while striving to bring innovative therapies to patients. Global Life Sciences Alliance (GLSA) addresses these challenges through their… Read more »
GLSA Site Nexus: Where Clinical Research Sites Connect, Grow, and Access Real Study Opportunities
Clinical research sites power every medical breakthrough, but too often, their potential is limited by isolation, outdated tools, and lost opportunities. GLSA Site Nexus was built to change that from the ground up, for sites like yours. Created by site leaders who understand the realities of patient recruitment, site engagement, and study startup, GLSA Site… Read more »
The August 2025 | GLSA Accelerated Partnering Session Recap
GLSA Accelerated Partnering Session Recap Event Date: August 2025 This month’s GLSA Accelerated Partnering Session participants came together for a focused exchange of ideas across the life sciences industry. Overall, the session explored clinical research site solutions, patient recruitment strategies, and early-phase trial opportunities. In addition, speakers examined how technology can improve efficiency across the life… Read more »
Why Relationship Building Matters More Than Ever | August 2025
Industry Headwinds: A Reality Check for Clinical Research and Business Development The clinical research sales cycle has become increasingly difficult to navigate amid ongoing industry headwinds. Over the past three years, economic uncertainty, supply chain disruptions, tariffs, FDA and NIH staffing changes, and rapid advances in AI have slowed investment and reshaped hiring and business… Read more »
The July 2025 FOCM | GLSA Networking Event
Fractional Talent in Life Sciences: Why HR & Leadership Matter More Than Ever Event Date: July 16, 2025 Fractional talent in life sciences is becoming a critical workforce strategy for biotech and pharma companies navigating rapid change. On July 16, the Global Life Sciences Alliance (GLSA) and FOCM (Friends of Chris Matheus) hosted a virtual… Read more »
July 2025 | Meatballs in Tomato Sauce
Homemade meatballs in tomato sauce are the ultimate comfort food, and this month Alexandre shares his irresistible take on this classic dish. These tender, perfectly seasoned meatballs simmer gently in a rich, aromatic tomato sauce, creating layers of flavor that bring warmth and joy to any table. Alexandre’s simple and thoughtful approach makes this recipe… Read more »
GLSA’s Patient-Centric Approach to Clinical Trials
Elevating Research Through Patient-Centric Strategies: The GLSA Approach to Recruitment, Engagement, and Retention The path from discovery to delivery is complex in both preclinical and clinical research. Challenges related to patient recruitment, engagement, and retention often determine whether a study succeeds or stalls. A patient-centric approach helps address these issues by placing the participant experience… Read more »
Unlocking Efficiency and Expertise: The Strategic Value of Fractional Service Providers in Drug Development and Medical Affairs
News from @MedSurgPI and @StarBioPharmaConsulting: How can early-stage biotechs access senior expertise without blowing the budget? In our latest white paper, we explore how fractional service providers (FSPs) are helping emerging drug developers streamline operations, reduce costs, and accelerate timelines—without sacrificing quality. From regulatory strategy to real-world evidence, discover how FSPs can drive smarter growth… Read more »